Alzheimer's Prevention: The Next Big Idea For Fixing Drug Trial Failures

Mass screening of asymptomatic people is an expensive, daunting proposition, but very preliminary research with an amyloid beta blood test is spurring hope that a more practical way to identify those at risk will emerge in the future.